11 / 17 / 2022
Check out – It’s our ‘UNSHAVED’ image for Movember!
Beyond the mustache, we at Explicyte are calling for awareness to ‘change the face’ of men’s health - mental health issues and especially cancers.
Let’s dig together into and mobilize around male cancer research!
10 / 27 / 2022
10 / 26 / 2022
Check out – It’s our favorite image of the PINK October!
More than a color, more than a month…
🎗Our everyday challenge by supporting cancer research, with a pink hope to win this fight!🎗
10 / 20 / 2022
We very much look forward to attending the @Society for Immunotherapy of Cancer Annual Meeting in Boston from November 8 to 12, and to showcasing our recent research works through our posters. Plan to stop by to talk of them and about your research programs.
Interested in meeting us to learn on our services offerings and how they can support your needs? Reach us for scheduling!
09 / 12 / 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
Journal of Hematology & Oncology, 2022, October 27
Mariella Spalato‑Ceruso, Fanny Bouteiller, Jean‑Philippe Guegan, Maud Toulmonde, Alban Bessede, Michèle Kind, Sophie Cousin, Xavier Buy, Jean Palussiere, François Le Loarer, Berengere Dadone‑Montaudie, Marina Pulido and Antoine Italiano
09 / 08 / 2022
Save the date for our new in vivo shuttle campaign!
We are committed to providing world-class supports to advance your preclinical projects and immunotherapy drug discovery using syngeneic tumor mouse models through our comprehensive in vivo Immuno-Oncology platform.
Sign up! It’s for early November
09 / 01 / 2022
Annals of Oncology, 2022, July 15
F Peyraud, J-P Guegan, D Bodet, I Nafia, L Fontan, C Auzanneau, S Cousin, G Roubaud, M Cabart, F Chomy, F Le Loarer, N Chaput, F-X Danlos, D Planchard, C Even, M Khettab, L Tselikas, B Besse, F Barlesi, J-C Soria, A Marabelle, A Bessede, A Italiano
08 / 01 / 2022
A novel gut-restricted small molecule TLR2 agonist enhances immune checkpoint inhibitor efficacy in a preclinical mouse fibrosarcoma tumor model
European journal of cancer, 2022, October 1
J. Simon, C.J. Oalmann, P. Stern, R.K. Senter, M. Chien, R. Graf, A. Bessede, A.S. Campbell
07 / 12 / 2022
Check out - it's our favorite image of the month
What a pretty multiplexed image showing the tumor microenvironment (TME) on a human NSCLC section, highlighting PDL1 positive tumor cells surrounded by macrophages and T cells.
07 / 07 / 2022
Discover our main news for the first half of 2022!
Hear about the great opportunity that is our partnership with Domain Therapeutics, new cutting-edge platforms for biomarker translational research as well as our newest featured publication!